Predicting COVID-19 prognosis in hospitalized patients based on early status

David Natanov1, Byron Avihai1, Erin McDonnell1

  • 1Rutgers Robert Wood Johnson Medical School , Piscataway, New Jersey, USA.

Mbio
|September 8, 2023
PubMed

Insights

Predicting COVID-19 patient outcomes is crucial. New models using age and lab tests offer a simple, efficient way to assess prognosis and guide critical care decisions.

Area of Science:

  • Medical Prognostics
  • Infectious Disease Epidemiology
  • Health Resource Management

Background:

  • COVID-19 is a leading cause of death, necessitating effective patient risk stratification.
  • Efficient allocation of critical care resources (ventilators, ICU beds) is vital during surges.
  • Accurate prognosis aids clinicians in managing patient care and difficult conversations.

Purpose of the Study:

  • To develop and validate predictive models for COVID-19 patient mortality risk.
  • To create tools that utilize readily available clinical data for rapid risk assessment.
  • To support clinical decision-making and resource management in COVID-19 care.

Main Methods:

  • Development of the PLABAC and PRABLE predictive models.
  • Utilized patient age and five common laboratory test results as input variables.
  • Validated model generalizability across diverse external patient populations in the US.

Main Results:

  • The PLABAC and PRABLE models accurately predict COVID-19 patient risk of death.
  • Models require only basic demographic and laboratory data for prognosis.
  • Demonstrated consistent performance and generalizability in external validation cohorts.

Conclusions:

  • PLABAC and PRABLE provide practical, efficient tools for assessing COVID-19 prognosis.
  • These models can serve as real-time aids for clinicians discussing patient outcomes.
  • The models facilitate better communication and resource allocation for COVID-19 patients.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
357
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
220
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
152
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381